BACKGROUNDIndividuals with human T-cell lymphotrophic virus type-1 (HTLV-1)/HIV-1 coinfection have been demonstrated to undergo CD4+ lymphocytosis even in the face of immunodeficiency and increased vulnerability to opportunistic pathogens that can lead to poor prognosis.OBJECTIVEThis study investigated the prevalence as well as the effects of HIV-1/HTLV-1 coinfection on CD4+ cell counts, routine hematology, and biochemical parameters of study participants.MATERIALS AND METHODSThis prospective cross-sectional study involved 184 blood samples collected from HIV-1-seropositive individuals attending HIV-special clinic of the University of Abuja Teaching Hospital, Gwagwalada, Nigeria. These samples were analyzed for anti-HTLV-1/2 IgM antibodies using enzyme-linked immunosorbent assay, CD4+ cell counts, and some routine hematological and biochemical parameters. All samples were also tested for HTLV-1 provirus DNA using real-time polymerase chain reaction (PCR) assay.RESULTSOf the 184 subjects studied, 9 (4.9%) were anti-HTLV-1/2 IgM seropositive; however, upon real-time PCR testing, 12 (6.5%) had detectable HTLV-1 provirus DNA. The CD4+ cell count was significantly high in HTLV-1-positive (742 ± 40.2) subjects compared to their HTLV-1-negative (380 ± 28.5) counterpart (P-value = 0.025). However, there was no significant association between HTLV-1 positivity with other hematology and biochemical parameters studied (P > 0.05).CONCLUSIONAll subjects (100%) who were HTLV-1/HIV-1-coinfected had normal CD4+ counts. This gives contrasting finding on the true extent of immunodeficiency of subjects. So it is suggested to be very careful in using only CD4+ counts to monitor disease progression and as indicators for antiretroviral therapy (ART) in resource-limited settings. In such conditions, there may be a need to test for HTLV-1 alongside HIV viral loads in order to begin appropriate ART regimens that contain both pathogens.

No abstract

No abstract

Prompt and accurate laboratory testing of women before or during antenatal days is necessary for detecting humoral immunological responses against cytomegalovirus (CMV) infection and assessing risk of congenital transmission. CMV is the most common viral etiology with the greatest propensity to induce neonatal pathologies. Most healthcare facilities in developing countries rely solely on anti-CMV IgM and IgG assays in diagnosing CMV infections. However, these parameters have some worrisome limitations. This study reviewed the significance of IgG avidity testing as a highly sensitive and specific tool that improves decisions regarding diagnosis of maternal and congenital CMV infections. We conducted this review from relevant published articles using an extensive literature search made through PubMed, Scopus and Google scholar on the concepts of congenital CMV (CCMV) transmission and clinical significance of IgG avidity testing in diagnosis of CCMV infections. Findings from our review revealed that IgG avidity testing in some developed societies was frequently utilized to resolve dilemmas associated with serodiagnosis of CMV infections, however, there is paucity of information in regards to its use in developing countries. The non-inclusion of IgG avidity testing during serological investigations of CMV could be a reason why congenital CMV infections and associated pathologies often go underdiagnosed in developing countries.

The incidence and case-fatality rates (CFRs) of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, the etiological agent for Coronavirus Disease 2019 (COVID-19), have been rising unabated. Even though the entire world has been implementing infection prevention and control measures, the pandemic continues to spread. It has been widely accepted that preventive vaccination strategies are the public health measures for countering this pandemic. This study critically reviews the latest scientific advancement in genomics, replication pattern, pathogenesis, and immunopathology of SARS-CoV-2 infection and how these concepts could be used in the development of vaccines. We also offer a detailed discussion on the anticipated potency, efficacy, safety, and pharmaco-economic issues that are and will be associated with candidate COVID-19 vaccines.

Cytomegalovirus (CMV) screening in pregnancy has not been recommended during antenatal clinic days in Nigeria and most countries of the world. However, CMV has been widely accepted as, the viral etiology with the greatest propensity for congenital transmission. Due to CMV ubiquity, seronegative women are highly susceptible to CMV infection and thus, has increased risk of maternal infections and possibly congenital transmission. In view of this, this study aimed to determine the seroprevalence of women, who are anti-CMV IgG seronegative, thus susceptible to CMV infections. We made use of Novalisa TM anti-CMV IgG ELISA kit to screen 182 blood samples of pregnant women attending antenatal clinics of University of Maiduguri Teaching Hospital (UMTH), Maiduguri, Nigeria. Structured questionnaire was used to collect participants' sociodemographic data. A total of 38 out of 182 subjects were anti-CMV IgG seronegative making a seroprevalence of 20.9%. There was significant statistical association between seronegativity and subjects' education level and history of previous blood transfusion (p<0.05) but not with age, parity, gravida and gestation age (p>0.05). Findings from our evaluation indicated that many pregnant women were anti-CMV IgG seronegative and thus susceptible to maternal CMV infections. These women have high risk of contacting primary CMV infections and might eventually pose danger to their unborn fetuses in the absence of appropriate preventive measures.

Bacterial contamination of intensive care units is of clinical concern because it is one of the major risk factors of ICU -acquired infections and centre point of multidrug resistant (MDR) pathogens. Periodic surveillance is an early warning signal to non-adherence of basic standard infection control procedures and emergence of MDR pathogens. This study evaluated the bacterial contamination, bacterial pathogens isolated and their antimicrobial susceptibility pattern in the ICU units. The units sampled were adult and neonatal intensive care units, accordingly to previously described methods and analyzed by standard microbiological methods. A total of 113 samples were collected, overall, 71(62.8%) yielded positive bacterial growth, 15(21.1%) detected by open-plate and 14(19.7%) by swabbing in adult intensive care unit and 20(28.2%) and 22(31.0%) in neonatal care unit. Bacillus spp,Staphylococcus aureus and coagulase negative staphylococci spp predominated in both units 24(33.8%), 19(26.8%), 14(19.7%), Other pathogens 19%, clinically relevant pathogens isolated were Eschericia coli (1%), Klebsiella pneumonia(4%) and Streptococcus pneumonia (3%) respectively. High indoor contamination was recorded in both units, 51.7% (n=15) in AICU and 47.6% (n=20) in NICU and inanimate items/equipments. Clinically relevant pathogens were recovered from routinely used equipment and critical sites. High resistance to commonly prescribed and administered agents, cotrimoxazole, amoxicillin and ampicillin was observed. Though the findings has provided a baseline information for furthered surveillance, but the high indoor contamination within both units signify increased traffic, ventilation system problem and inadequate cleaning procedures.

No abstract